Preclinical realities, therapeutic momentum, and generative AI in drug discovery ...
This oncology biotech advancing targeted therapies reported a notable insider sale amid ongoing clinical-stage development.
A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the ...
Germany’s Merck KGaA will buy Bio-Techne Corp. in a deal worth $11.3 billion, one of the largest acquisitions in Minnesota ...
Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. David Meek bought Bluebird Bio last year ...
Merck KGaA agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the ...
German drugmaker Merck KGaA said on Thursday it would buy U.S. firm Bio-Techne for $11.3 billion, its biggest deal in more ...
Zacks Investment Research on MSN
Is Adicet Bio (ACET) stock outpacing its medical peers this year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Adicet Bio, Inc. (ACET) been one of those stocks this year?
Orca Bio has jumped into the commercial market with FDA approval for Tregzi, a first-of-its-kind engineered cell therapy for blood cancer patients requiring transplants. Tuesday, the FDA approved the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results